Table 1.

Basic and Demographic Features, MetS, and Non-MetS in the Patients (n=82

		MetS (n=55) n (%)	Non-MetS (n=27) n (%)	P-value
Gender	Female	22(40%)	5(18.5%)	0.052
	Male	33(60%)	22(81.5%)
Age (year) mean±SD		43.69±10.27	38.85±9.43	0.043*
WCa(cm) mean±SD		104.4±7.5	100.2±9.4	0.03*
TGb (mg/dL) mean±SD		235.6±173.5	159.6±65.9	0.006*
HDLc (mg/dL)mean±SD		34.5±10.3	38.6±12.5	0.125
FBSd (mg/dL) mean±SD		106±35.7	92.2±24.2	0.075
HTNe positive patients (%)		31(56.4%)	7(26%)	0.009*
BMIf (kg/m2) mean±SD		31.9±3.7	29.5±3.8	0.007*
TSHg (UI/mL) mean±SD		2.9±0.86	2.8±1.2	0.636
T3h (ng/dL) mean±SD		122.6±16.7	123.8±20.25	0.77
T4I (ng/dL) mean±SD		7.3±1.7	7.6±1.2	0.49
hs-CRPj (mg/dL) mean±SD		25.7±12.6	20.2±9.8	0.049*

^a Waist circumference;

^b Triglyceride;

^cHigh density lipoprotein;

^dFasting blood sugar;

^eHypertension;

^f Body mass index;

^g Thyroid stimulating hormone;

^hTriiodothyronine;

^IThyroxine;

^j  high-sensitivity C-reactive protein;

^* Significant P-value